Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


Articles published in Eur J Surg Oncol

Retrieve available abstracts of 87 articles:
HTML format
Text format



Single Articles


    July 2018
  1. NAZZANI S, Preisser F, Mazzone E, Tian Z, et al
    In-hospital length of stay after major surgical oncological procedures.
    Eur J Surg Oncol. 2018;44:969-974.
    PubMed     Text format     Abstract available


  2. NOWACKI M, Alyami M, Villeneuve L, Mercier F, et al
    Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
    Eur J Surg Oncol. 2018;44:991-996.
    PubMed     Text format     Abstract available


    June 2018
  3. HUANG SF, Chien TH, Fang WL, Wang F, et al
    The 8th edition American Joint Committee on gastric cancer pathological staging classification performs well in a population with high proportion of locally advanced disease.
    Eur J Surg Oncol. 2018 Jun 11. pii: S0748-7983(18)31120.
    PubMed     Text format     Abstract available


  4. QUAN B, Yan WT, Yu JJ, Shen F, et al
    Relationship between complications and long-term prognosis after total gastrectomy with splenectomy for proximal advanced gastric cancer.
    Eur J Surg Oncol. 2018 Jun 5. pii: S0748-7983(18)31077.
    PubMed     Text format    


    May 2018
  5. LIN JX, Lin JP, Li P, Xie JW, et al
    Which staging system better predicts 10-year survival for gastric cancer? A study using an international multicenter database.
    Eur J Surg Oncol. 2018 May 17. pii: S0748-7983(18)31068.
    PubMed     Text format     Abstract available


  6. FERNANDEZ JA, Gomez-Ruiz AJ, Olivares V, Ferri B, et al
    Clinical and pathological features of "small" GIST (</=2 cm). What is their prognostic value?
    Eur J Surg Oncol. 2018;44:580-586.
    PubMed     Text format     Abstract available


  7. WHIBLEY J, Peters CJ, Halliday LJ, Chaudry AM, et al
    Poor performance in incremental shuttle walk and cardiopulmonary exercise testing predicts poor overall survival for patients undergoing esophago-gastric resection.
    Eur J Surg Oncol. 2018;44:594-599.
    PubMed     Text format     Abstract available


    March 2018
  8. CARMONA-BAYONAS A, Jimenez-Fonseca P, Echavarria I, Sanchez Canovas M, et al
    Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
    Eur J Surg Oncol. 2018 Mar 31. pii: S0748-7983(18)30988.
    PubMed     Text format     Abstract available


  9. MORGAGNI P, Solaini L, Saragoni L, Bencivenga M, et al
    An aggressive early gastric cancer: Kodama's PenA type.
    Eur J Surg Oncol. 2018 Mar 27. pii: S0748-7983(18)30985.
    PubMed     Text format     Abstract available


  10. WATANABE M, Kinoshita T, Tokunaga M, Kaito A, et al
    Complications and their correlation with prognosis in patients undergoing total gastrectomy with splenectomy for treatment of proximal advanced gastric cancer.
    Eur J Surg Oncol. 2018 Mar 23. pii: S0748-7983(18)30961.
    PubMed     Text format     Abstract available


  11. POLOM K, Boger C, Smyth E, Marrelli D, et al
    Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency.
    Eur J Surg Oncol. 2018 Mar 2. pii: S0748-7983(18)30882.
    PubMed     Text format     Abstract available


    February 2018
  12. ALLUM W
    Essential requirements for quality cancer care - Oesophageal and gastric cancer.
    Eur J Surg Oncol. 2018 Feb 16. pii: S0748-7983(18)30668.
    PubMed     Text format    


  13. MIYAMOTO R, Inagawa S, Sano N, Tadano S, et al
    The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients.
    Eur J Surg Oncol. 2018 Feb 13. pii: S0748-7983(18)30296.
    PubMed     Text format     Abstract available


  14. CLAASSEN YHM, Hartgrink HH, Dikken JL, de Steur WO, et al
    Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial.
    Eur J Surg Oncol. 2018 Feb 9. pii: S0748-7983(18)30297.
    PubMed     Text format     Abstract available


  15. WANG PL, Huang JY, Zhu Z, Gong BC, et al
    Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients.
    Eur J Surg Oncol. 2018 Feb 3. pii: S0748-7983(18)30289.
    PubMed     Text format     Abstract available


  16. MORALES-SORIANO R, Esteve-Perez N, Segura-Sampedro JJ, Cascales-Campos P, et al
    Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey.
    Eur J Surg Oncol. 2018;44:228-236.
    PubMed     Text format     Abstract available


    January 2018
  17. AGNES A, Lirosi MC, Panunzi S, Santocchi P, et al
    The prognostic role of perioperative allogeneic blood transfusions in gastric cancer patients undergoing curative resection: A systematic review and meta-analysis of non-randomized, adjusted studies.
    Eur J Surg Oncol. 2018 Jan 12. pii: S0748-7983(18)30014.
    PubMed     Text format     Abstract available


  18. SCHOUWENBURG MG, Busweiler LAD, Beck N, Henneman D, et al
    Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit.
    Eur J Surg Oncol. 2018 Jan 12. pii: S0748-7983(18)30035.
    PubMed     Text format     Abstract available


  19. VARAGUNAM M, Hardwick R, Riley S, Chadwick G, et al
    Changes in volume, clinical practice and outcome after reorganisation of oesophago-gastric cancer care in England: A longitudinal observational study.
    Eur J Surg Oncol. 2018 Jan 11. pii: S0748-7983(18)30008.
    PubMed     Text format     Abstract available


  20. HAGA Y, Hato S, Ikenaga M, Yamamoto K, et al
    Validation of an assessment tool: Estimation of Postoperative Overall Survival for Gastric Cancer.
    Eur J Surg Oncol. 2018 Jan 11. pii: S0748-7983(18)30010.
    PubMed     Text format     Abstract available


    December 2017
  21. BECK N, Busweiler LAD, Schouwenburg MG, Fiocco M, et al
    Factors contributing to variation in the use of multimodality treatment in patients with gastric cancer: A Dutch population based study.
    Eur J Surg Oncol. 2017 Dec 13. pii: S0748-7983(17)31013.
    PubMed     Text format     Abstract available


    October 2017
  22. VISSER E, Brenkman HJF, Verhoeven RHA, Ruurda JP, et al
    Weekday of gastrectomy for cancer in relation to mortality and oncological outcomes - A Dutch population-based cohort study.
    Eur J Surg Oncol. 2017;43:1862-1868.
    PubMed     Text format     Abstract available


    September 2017
  23. AYUBI E, Safiri S
    Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery; methodological issues.
    Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30658.
    PubMed     Text format    


  24. LIN JX, Huang CM, Zheng CH, Li P, et al
    Is it necessary to dissect the posterior lymph nodes along the splenic vessels during total gastrectomy with D2 lymphadenectomy for advanced gastric cancer?
    Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30694.
    PubMed     Text format     Abstract available


  25. POLOM K, Marrelli D, Pascale V, Ferrara F, et al
    The pattern of lymph node metastases in microsatellite unstable gastric cancer.
    Eur J Surg Oncol. 2017 Sep 14. pii: S0748-7983(17)30665.
    PubMed     Text format     Abstract available


  26. LU J, Zheng CH, Cao LL, Li P, et al
    The effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of gastric cancer patients: A comparative study between the 7th and 8th editions.
    Eur J Surg Oncol. 2017 Sep 13. pii: S0748-7983(17)30659.
    PubMed     Text format     Abstract available


  27. GALLEBERG RB, Knigge U, Tiensuu Janson E, Vestermark LW, et al
    Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
    Eur J Surg Oncol. 2017;43:1682-1689.
    PubMed     Text format     Abstract available


  28. TOMASELLO G, Petrelli F, Ghidini M, Pezzica E, et al
    Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies.
    Eur J Surg Oncol. 2017;43:1607-1616.
    PubMed     Text format     Abstract available


    August 2017
  29. KATAOKA K, Deleersnijder A, Lordick F
    Will molecular target agents enable the multidisciplinary treatment in stage IV gastric cancer?
    Eur J Surg Oncol. 2017 Aug 30. pii: S0748-7983(17)30644.
    PubMed     Text format     Abstract available


  30. RONELLENFITSCH U, Schwarzbach M, Hofheinz R, Kienle P, et al
    Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).
    Eur J Surg Oncol. 2017;43:1550-1558.
    PubMed     Text format     Abstract available


    July 2017
  31. BUSWEILER LA, Henneman D, Dikken JL, Fiocco M, et al
    Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.
    Eur J Surg Oncol. 2017 Jul 29. pii: S0748-7983(17)30589.
    PubMed     Text format     Abstract available


    June 2017
  32. HUBNER M, Grass F, Teixeira-Farinha H, Pache B, et al
    Pressurized IntraPeritoneal Aerosol Chemotherapy - Practical aspects.
    Eur J Surg Oncol. 2017;43:1102-1109.
    PubMed     Text format     Abstract available


    May 2017
  33. REIM D, Choi YS, Yoon HM, Park B, et al
    Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection.
    Eur J Surg Oncol. 2017 May 3. pii: S0748-7983(17)30447.
    PubMed     Text format     Abstract available


    April 2017
  34. MILONE M, Elmore U, Musella M, Parise P, et al
    Safety and efficacy of laparoscopic wedge gastrectomy for large gastrointestinal stromal tumors.
    Eur J Surg Oncol. 2017;43:796-800.
    PubMed     Text format     Abstract available


  35. KESHAVA HB, Rosen JE, DeLuzio MR, Kim AW, et al
    "What if I do nothing?" The natural history of operable cancer of the alimentary tract.
    Eur J Surg Oncol. 2017;43:788-795.
    PubMed     Text format     Abstract available


    March 2017
  36. BOULIARIS K, Rachiotis G, Diamantis A, Christodoulidis G, et al
    Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system.
    Eur J Surg Oncol. 2017 Mar 27. pii: S0748-7983(17)30430.
    PubMed     Text format     Abstract available


  37. SASAKO M
    Is there role for laparoscopic gastrectomy for advanced gastric cancer.
    Eur J Surg Oncol. 2017 Mar 8. pii: S0748-7983(17)30363.
    PubMed     Text format    


  38. CHOI YY, Cheong JH
    Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
    Eur J Surg Oncol. 2017 Mar 1. pii: S0748-7983(17)30360.
    PubMed     Text format     Abstract available


    February 2017
  39. NORERO E, Vega EA, Diaz C, Cavada G, et al
    Improvement in postoperative mortality in elective gastrectomy for gastric cancer: Analysis of predictive factors in 1066 patients from a single centre.
    Eur J Surg Oncol. 2017 Feb 10. pii: S0748-7983(17)30050.
    PubMed     Text format     Abstract available


  40. CLIMENT M, Munarriz M, Blazeby JM, Dorcaratto D, et al
    Weight loss and quality of life in patients surviving 2 years after gastric cancer resection.
    Eur J Surg Oncol. 2017 Feb 9. pii: S0748-7983(17)30337.
    PubMed     Text format     Abstract available


  41. BOURAS G, Markar SR, Burns EM, Huddy JR, et al
    The psychological impact of symptoms related to esophagogastric cancer resection presenting in primary care: A national linked database study.
    Eur J Surg Oncol. 2017;43:454-460.
    PubMed     Text format     Abstract available


    January 2017
  42. KAITO A, Kinoshita T, Shitara K, Shibasaki H, et al
    Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery.
    Eur J Surg Oncol. 2017 Jan 29. pii: S0748-7983(17)30058.
    PubMed     Text format     Abstract available


  43. LEHMANN K, Eshmuminov D, Bauerfeind P, Gubler C, et al
    18FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma.
    Eur J Surg Oncol. 2017;43:196-202.
    PubMed     Text format     Abstract available


  44. KIM S, Paget-Bailly S, Messager M, Nguyen T, et al
    Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma.
    Eur J Surg Oncol. 2017;43:218-225.
    PubMed     Text format     Abstract available


  45. PARRY K, van Rossum PS, Haj Mohammad N, Ruurda JP, et al
    The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis.
    Eur J Surg Oncol. 2017;43:226-233.
    PubMed     Text format     Abstract available


    December 2016
  46. TU RH, Lin JX, Zheng CH, Li P, et al
    Development of a nomogram for predicting the risk of anastomotic leakage after a gastrectomy for gastric cancer.
    Eur J Surg Oncol. 2016 Dec 20. pii: S0748-7983(16)31052.
    PubMed     Text format     Abstract available


  47. PARK JM, Kim HI, Han SU, Yang HK, et al
    Who may benefit from robotic gastrectomy?: A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy.
    Eur J Surg Oncol. 2016;42:1944-1949.
    PubMed     Text format     Abstract available


    October 2016
  48. XIE JW, Sun YQ, Feng CY, Zheng CH, et al
    Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma.
    Eur J Surg Oncol. 2016;42:1464-70.
    PubMed     Text format     Abstract available


  49. MOSQUERA C, Koutlas NJ, Fitzgerald TL
    Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
    Eur J Surg Oncol. 2016;42:1471-7.
    PubMed     Text format     Abstract available


    September 2016
  50. LEE JH, Kang JW, Nam BH, Cho GS, et al
    Correlation between lymph node count and survival and a reappraisal of lymph node ratio as a predictor of survival in gastric cancer: A multi-institutional cohort study.
    Eur J Surg Oncol. 2016 Sep 30. pii: S0748-7983(16)30895.
    PubMed     Text format     Abstract available


  51. LOU N, Chi CH, Chen XD, Zhou CJ, et al
    Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: A prospective study.
    Eur J Surg Oncol. 2016 Sep 17. pii: S0748-7983(16)30894.
    PubMed     Text format     Abstract available


  52. MESSAGER M, de Steur W, Boelens PG, Jensen LS, et al
    Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).
    Eur J Surg Oncol. 2016;42:1432-47.
    PubMed     Text format     Abstract available


    August 2016
  53. KOMATSU S, Ichikawa D, Nishimura M, Kosuga T, et al
    Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer.
    Eur J Surg Oncol. 2016 Aug 21. pii: S0748-7983(16)30839.
    PubMed     Text format     Abstract available


  54. WU HT, Li Y
    Reply to: Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016).
    Eur J Surg Oncol. 2016 Aug 12. pii: S0748-7983(16)30638.
    PubMed     Text format    


  55. MARANO L, Marrelli D, Roviello F
    Focus on research: Nodal dissection for gastric cancer - A dilemma worthy of King Solomon!
    Eur J Surg Oncol. 2016 Aug 11. pii: S0748-7983(16)30838.
    PubMed     Text format    


  56. KIM JW, Choi SH
    Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016).
    Eur J Surg Oncol. 2016 Aug 11. pii: S0748-7983(16)30639.
    PubMed     Text format    


  57. MAKUUCHI R, Sugisawa N, Kaji S, Hikage M, et al
    Enhanced recovery after surgery for gastric cancer and an assessment of preoperative carbohydrate loading.
    Eur J Surg Oncol. 2016 Aug 10. pii: S0748-7983(16)30834.
    PubMed     Text format     Abstract available


  58. CAPELLI L, Petracci E, Quagliuolo V, Saragoni L, et al
    Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.
    Eur J Surg Oncol. 2016;42:1206-14.
    PubMed     Text format     Abstract available


  59. KULIG P, Sierzega M, Pach R, Kolodziejczyk P, et al
    Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.
    Eur J Surg Oncol. 2016;42:1215-21.
    PubMed     Text format     Abstract available


  60. O'NEILL AC, Shinagare AB, Kurra V, Tirumani SH, et al
    Assessment of metastatic risk of gastric GIST based on treatment-naive CT features.
    Eur J Surg Oncol. 2016;42:1222-8.
    PubMed     Text format     Abstract available


    July 2016
  61. RAMOS RF, Scalon FM, Scalon MM, Dias DI, et al
    Staging laparoscopy in gastric cancer to detect peritoneal metastases: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2016 Jul 9. pii: S0748-7983(16)30633.
    PubMed     Text format     Abstract available


    June 2016
  62. RAUSEI S, Ruspi L, Rosa F, Morgagni P, et al
    Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study.
    Eur J Surg Oncol. 2016 Jun 1. pii: S0748-7983(16)30153.
    PubMed     Text format     Abstract available


  63. YANG Y, Gao P, Song Y, Sun J, et al
    The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis.
    Eur J Surg Oncol. 2016 Jun 1. pii: S0748-7983(16)30180.
    PubMed     Text format     Abstract available


    May 2016
  64. WU HT, Peng KW, Ji ZH, Sun JH, et al
    Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center.
    Eur J Surg Oncol. 2016 May 3. pii: S0748-7983(16)30114.
    PubMed     Text format     Abstract available


    April 2016
  65. TIBERIO GA, Ministrini S, Gardini A, Marrelli D, et al
    Factors influencing survival after hepatectomy for metastases from gastric cancer.
    Eur J Surg Oncol. 2016 Apr 19. pii: S0748-7983(16)30047.
    PubMed     Text format     Abstract available


  66. COCCOLINI F, Catena F, Glehen O, Yonemura Y, et al
    Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis.
    Eur J Surg Oncol. 2016 Apr 19. pii: S0748-7983(16)30053.
    PubMed     Text format     Abstract available


  67. YONEMURA Y, Canbay E, Li Y, Coccolini F, et al
    A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.
    Eur J Surg Oncol. 2016 Apr 9. pii: S0748-7983(16)30025.
    PubMed     Text format     Abstract available


    March 2016
  68. KOIZUMI N, Harada Y, Beika M, Minamikawa T, et al
    Highly sensitive fluorescence detection of metastatic lymph nodes of gastric cancer with photo-oxidation of protoporphyrin IX.
    Eur J Surg Oncol. 2016 Mar 31. pii: S0748-7983(16)00381.
    PubMed     Text format     Abstract available


  69. YAMASHITA K, Hosoda K, Ema A, Watanabe M, et al
    Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer.
    Eur J Surg Oncol. 2016 Mar 15. pii: S0748-7983(16)00379.
    PubMed     Text format     Abstract available


  70. PARRY K, Haverkamp L, Bruijnen RC, Siersema PD, et al
    Staging of adenocarcinoma of the gastroesophageal junction.
    Eur J Surg Oncol. 2016;42:400-6.
    PubMed     Text format     Abstract available


    January 2016
  71. MORITA S, Fukagawa T, Fujiwara H, Katai H, et al
    The clinical significance of para-aortic nodal dissection for advanced gastric cancer.
    Eur J Surg Oncol. 2016 Jan 26. pii: S0748-7983(16)00044.
    PubMed     Text format     Abstract available


    December 2015
  72. ZHOU CJ, Chen FF, Zhuang CL, Pang WY, et al
    Feasibility of radical gastrectomy for elderly patients with gastric cancer.
    Eur J Surg Oncol. 2015 Dec 6. pii: S0748-7983(15)00894.
    PubMed     Text format     Abstract available


    November 2015
  73. MARANO L, Polom K, Patriti A, Roviello G, et al
    Surgical management of advanced gastric cancer: An evolving issue.
    Eur J Surg Oncol. 2015 Nov 14. pii: S0748-7983(15)00840.
    PubMed     Text format     Abstract available


    October 2015
  74. NORERO E, Bustos M, Herrera ME, Cerda J, et al
    Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Eur J Surg Oncol. 2015 Oct 24. pii: S0748-7983(15)00825.
    PubMed     Text format     Abstract available


  75. HAVERKAMP L, Ruurda JP, Offerhaus GJ, Weijs TJ, et al
    Laparoscopic gastrectomy in Western European patients with advanced gastric cancer.
    Eur J Surg Oncol. 2015 Oct 22. pii: S0748-7983(15)00793.
    PubMed     Text format     Abstract available


  76. GLATZ T, Bronsert P, Schafer M, Kulemann B, et al
    Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.
    Eur J Surg Oncol. 2015;41:1300-7.
    PubMed     Text format     Abstract available


  77. MINE S, Kurokawa Y, Takeuchi H, Kishi K, et al
    Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Eur J Surg Oncol. 2015;41:1348-53.
    PubMed     Text format     Abstract available


    September 2015
  78. MESSAGER M, de Steur WO, van Sandick JW, Reynolds J, et al
    Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
    Eur J Surg Oncol. 2015 Sep 30. pii: S0748-7983(15)00792.
    PubMed     Text format     Abstract available


  79. CLIMENT M, Hidalgo N, Vidal O, Puig S, et al
    Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.
    Eur J Surg Oncol. 2015 Sep 3. pii: S0748-7983(15)00735.
    PubMed     Text format     Abstract available


  80. BARCHI LC, Yagi OK, Jacob CE, Mucerino DR, et al
    Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
    Eur J Surg Oncol. 2015 Sep 3. pii: S0748-7983(15)00736.
    PubMed     Text format     Abstract available


    July 2015
  81. YAMASHITA K, Ushiku H, Katada N, Hosoda K, et al
    Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    Eur J Surg Oncol. 2015 Jul 29. pii: S0748-7983(15)00479.
    PubMed     Text format     Abstract available



  82. Retraction notice to "Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of randomized controlled trials" [Eur J Surg Oncol 40 (10) (October 2014) 1321-1330].
    Eur J Surg Oncol. 2015;41:953.
    PubMed     Text format    


  83. GOH BK, Goh YC, Eng AK, Chan WH, et al
    Outcome after laparoscopic versus open wedge resection for suspected gastric gastrointestinal stromal tumors: A matched-pair case-control study.
    Eur J Surg Oncol. 2015;41:905-10.
    PubMed     Text format     Abstract available


    June 2015
  84. WANG Y, Shen C, Ge J, Duan H, et al
    Regular aspirin use and stomach cancer risk in China.
    Eur J Surg Oncol. 2015;41:801-4.
    PubMed     Text format     Abstract available


    May 2015
  85. SCHMIDT T, Alldinger I, Blank S, Klose J, et al
    Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
    Eur J Surg Oncol. 2015 May 29. pii: S0748-7983(15)00436.
    PubMed     Text format     Abstract available


  86. KINOSHITA J, Fushida S, Tsukada T, Oyama K, et al
    Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
    Eur J Surg Oncol. 2015 May 15. pii: S0748-7983(15)00429.
    PubMed     Text format     Abstract available


  87. YAMAGUCHI H, Kitayama J, Emoto S, Ishigami H, et al
    Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Eur J Surg Oncol. 2015 May 8. pii: S0748-7983(15)00415.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: